Clinical trial NCT02752282: Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction
Official title: Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Vaginal Bleeding
Uterine Cramping
Keywords: Family Planning
LNG-IUS
Health Education
Lead sponsor: University of Washington
Sponsor class: OTHER
Collaborators: name: Bayer
name: Cook County Health
name: University of California, Los Angeles
First posted: 2016-04-26
Enrollment: 178
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: This study is a counseling intervention for new LNG-IUS users. The study explores the use of video technology to deliver anticipatory counseling on LNG-IUS side-effects, adjustment periods and bleeding changes to women newly using the LNG-IUS for contraceptive purposes. The primary aim is to understand if anticipatory counseling delivered via video can increase LNG-IUS satisfaction and continuation of the device in the first 6 months of use.

Detailed description: Enhanced anticipatory counseling detailing side effects when initiating progestin-only injectable contraception improved its continued use among women.While continuation rates at one year among levonorgestrel intrauterine system (LNG-IUS) users are considerably higher than those for progestin-only injectable users in the United States (80% versus 56%), enhanced anticipatory counseling could have an impact on the 20% of LNG IUS users who choose to discontinue the method within one year of use. For this reason, the investigators propose a study that would develop and pilot-test an anticipatory counseling intervention detailing unscheduled bleeding and other side effects such as pelvic pain or cramping among new LNG IUS users and compare this with a "control," using video technology. The investigators have chosen video technology for the counseling intervention to ensure that all participants receive the exact same information about LNG side effects, which would be not possible using a face-to-face clinician-participant counseling model.

The investigators propose three phases for this study. In Phase 1, a systematic literature search evaluating effective components in videos used for contraceptive counseling and the development of two separate video scripts will lead to: (1) an intervention, detailing expected side effects and safety of the LNG IUS, and (2) a similar-looking "control," detailing only recommended screening guidelines for women, as well as information about LNG IUS safety. This phase of the study uses focus groups prior to the development of the video interventions, initially with family planning experts for content accuracy and cultural sensitivity, and secondarily with new LNG IUS users for acceptability. Findings from this phase will be used to fine-tune the scripts prior to the development of the videos.

In Phase 2 of the study, the investigators will pilot a trial in the clinical setting to evaluate the anticipatory counseling video intervention and its impact on LNG-IUS knowledge, continuation, health care utilization, and satisfaction. After receiving comprehensive contraceptive counseling from their clinicians, women who choose to have the LNG IUS inserted will be given a brochure that asks them to participate in an online study. After signing-on to an innovative website, participants will be randomized to either an intervention or control video and complete short questionnaires related to demographics, baseline menstruation, satisfaction, and LNG IUS knowledge before and after viewing their assigned video. Women will be followed for six months. They will be asked to complete a short online survey at three and six months regarding LNG IUS continuation, health care utilization, and satisfaction. Findings from this study will serve to design a future, appropriately powered randomized controlled trial assessing LNG IUS continuation, utilization, and satisfaction rates at 12 months.

In Phase 3, we will use the findings from Phase 2 to develop a similar protocol and recruit up to 178 women at three sites across the US to test the same primary aims of the video: LNG-IUS continuation, utilization, and satisfaction over a 12 month period. In phase 3, subjects will be randomized to watch either the control or intervention video.

Eligibility criteria: Inclusion Criteria:

1. Women aged 18 and over who are deemed appropriate candidates be their healthcare providers and choose to use LNG-IUS, either Mirena or Skyla.
2. Within five days of FIRST using either Mirena or Skyla
3. Willing to answer online questions before and after watching the assigned video (intervention or control)
4. Willing to complete short online questionnaire at three and six months
5. Has working email and/or phone number
6. Able to understand verbal and written English
7. Appropriate LNG-IUS candidates whoa re being treated for other pre-existing medical disorders while using the LNG IUS may continue to take their medications as directed by their healthcare provider.

Exclusion Criteria:

1. Women aged less than 18 years old
2. Initiated LNG-IUS method more than five days from enrollment date.
3. Within six weeks postpartum
4. Breastfeeding
5. Using LNG-IUS for treatment other than contraception
6. Do not have access to the Web
7. Have neither working email or phone number
8. Does not understand written or verbal English
9. Inappropriate candidates for LNG IUS as deemed by healthcare provider

Primary outcomes:
measure: Change in LNG-IUS knowledge, satisfaction and continuation from baseline
timeFrame: 6 months
Secondary outcomes:
measure: Percent of subjects in Phase II who complete all 3 surveys on-time over 6 months compared by recruitment method and site
timeFrame: 6 months
measure: Number of subjects reporting LNG-IUS discontinuation during the study time frame (6 months) by reason for LNG-IUS removal
timeFrame: 6 months
measure: LNG-IUS user self-reported satisfaction with video counseling
timeFrame: 6 months
measure: LNG-IUS user self-reported LNG-IUS healthcare utilization during study period
timeFrame: baseline, 3 months, 6 months
Other outcomes:
Locations:
city: Los Angeles
country: United States
facility: University of California Los Angeles Medical Center
state: California
city: Chicago
country: United States
facility: Stroger Hospital of Cook County
state: Illinois
city: Seattle
country: United States
facility: University of Washington Medical Centers
state: Washington
Study officials:
affiliation: University of Washington
name: Emily Godfrey, MD, MPH
role: PRINCIPAL_INVESTIGATOR
References: